Fundamentals Hub
ABPWW Abpro Holdings, Inc.
ABPWW financial statements, revenue, balance sheet, cash flow, and SEC filings
Showing 3 of 4 annual and 0 of 18 quarterly periods.
Full history available with a free account or via API.
▼ Company Profile
Filer Category
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity Type
Operating
Public Float
$9.30M (Jun 2025)
Industry (SIC)
2836 Biological Products, (No Diagnostic Substances)
Incorporated
DE
Fiscal Year End
December (1231)
Phone
248-890-7200
EIN
871013956
Headquarters
NEW YORK, NY, 10013
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
Former Names:
Atlantic Coastal Acquisition Corp. II (2021–2024)
▼ Key Metrics (TTM)
As of Jun 30, 2026Financials
Revenue
-
Net Income
-
Total Assets
$5.24M
Total Equity
$-2.98M
Total Debt
-
Free Cash Flow
-
Ratios
Current Ratio
0.62x
Sources and calculation details
Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.
Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.
Annual (FY)
Quarterly 🔒
Chart 🔒
| Metric | FY2025 📄 | FY2024 📄 | FY2023 📄 |
|---|---|---|---|
| Income Statement | |||
| REVENUE | |||
| Revenue | - | $183.00K | $122.00K |
| OPERATING EXPENSES | |||
| R&D Expense | $989.00K | $2.98M | $4.27M |
| SG&A Expense | $7.46M | $7.12M | $7.60M |
| Operating Income | $-8.45M | $-9.92M | $-11.75M |
| NON-OPERATING INCOME / EXPENSE | |||
| Interest Income | $33.00K | $9.00K | $52.30K |
| Other Income/Expense | $5.56M | $2.69M | $40.00K |
| Pretax Income | - | $-7.23M | $-11.71M |
| Income Tax | - | - | $1.18M |
| Net Income | - | - | $2.82M |
| PER SHARE & SUPPLEMENTAL | |||
| Diluted EPS | $-1.30 | $-22.31 | $-0.61 |
| Diluted Shares | 2.23M | 780.33K | 19.13M |
| EBITDA | $-8.43M | $-9.85M | $-11.47M |
| Depreciation & Amortization | $21.00K | $74.00K | $279.00K |
| Balance Sheet | |||
| ASSETS | |||
| Cash & Equivalents | $82.00K | $2.85M | $723.00K |
| Accounts Receivable | $183.00K | $323.00K | $88.00K |
| Other Current Assets | $480.00K | $306.00K | $208.00K |
| Current Assets | $896.00K | $3.78M | $2.04M |
| PP&E (Net) | - | $37.00K | $102.00K |
| Noncurrent Assets | $167.00K | $885.00K | $1.32M |
| Total Assets | $1.06M | $4.66M | $3.36M |
| LIABILITIES | |||
| Accounts Payable | $5.32M | $3.94M | $7.92M |
| Other Current Liabilities | $1.14M | $865.00K | $590.00K |
| Current Liabilities | $9.35M | $19.61M | $15.74M |
| Other Noncurrent Liabilities | - | $6.60M | - |
| Noncurrent Liabilities | $0 | $0 | $455.00K |
| Total Liabilities | $9.35M | $19.61M | $16.19M |
| EQUITY | |||
| Common Stock | - | $5.00K | $2.00K |
| Additional Paid-in Capital | $110.16M | $100.60M | $19.92M |
| Retained Earnings | $-119.00M | $-116.10M | $-108.87M |
| Total Equity | $-8.28M | $-14.95M | $-88.44M |
| Temporary Equity | - | - | $75.60M |
| Total Liabilities & Equity | $1.06M | $4.66M | $3.36M |
| SUPPLEMENTAL | |||
| Shares Outstanding | 2.73M | 1.69M | 19.17M |
| Check: A − (L + E + Temp. Equity) | - | - | - |
| Cash Flow Statement | |||
| Cash from Operations | $-6.01M | $-9.03M | $-7.40M |
| Capital Expenditures | - | - | $48.00K |
| Cash from Investing | - | $0 | $278.44M |
| Cash from Financing | $3.07M | $11.16M | $849.00K |
| Free Cash Flow | - | - | $-7.45M |
| Beginning Cash (CFS) | $2.99M | $861.00K | $7.46M |
| Net Change in Cash | - | $2.13M | $271.89M |
| Effect of FX on Cash | - | - | - |
| Calculated Ending Cash | - | $2.99M | $279.35M |
| Cash per BS | $82.00K | $2.85M | $723.00K |
| Cash scope difference (CFS − BS) | - | $142.00K | $138.00K |
| Cash per CFS | $82.00K | $2.99M | $861.00K ! |
Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.
Create Free Account Log In🔒
Quarterly data and charts require a free account
Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.